Guangdong Zhongsheng Pharmaceutical Co Ltd Working Capital to Net Assets Ratio
Guangdong Zhongsheng Pharmaceutical Co Ltd working capital to net assets ratio. Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Working Capital to Net Assets ratio of 55.0% as of September 2025. Working capital of CN¥2.27 Billion (current assets of CN¥3.10 Billion minus current liabilities of CN¥830.22 Million) is measured against net assets of CN¥4.13 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 002317 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Working capital to net assets ratio of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. This chart shows how Guangdong Zhongsheng Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2006 to 2024. As of September 2025, the ratio stands at 55.0%, reflecting working capital of CN¥2.27 Billion against net assets of CN¥4.13 Billion CNY. See Guangdong Zhongsheng Pharmaceutical Co L liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Guangdong Zhongsheng Pharmaceutical Co Ltd Working Capital to Net Assets Ratio by Year (2006–2024)
Guangdong Zhongsheng Pharmaceutical Co Ltd working capital to net assets ratio by year from 2006 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Guangdong Zhongsheng Pharmaceutical Co L assets under control.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 56.3% | CN¥2.26 Billion | CN¥4.01 Billion | CN¥3.46 Billion | CN¥1.20 Billion | ▼ -8.7 pp |
| 2023 | 65.1% | CN¥2.95 Billion | CN¥4.53 Billion | CN¥3.96 Billion | CN¥1.02 Billion | ▲ +9.4 pp |
| 2022 | 55.7% | CN¥2.13 Billion | CN¥3.82 Billion | CN¥3.23 Billion | CN¥1.11 Billion | ▼ -5.0 pp |
| 2021 | 60.7% | CN¥2.15 Billion | CN¥3.54 Billion | CN¥2.67 Billion | CN¥524.20 Million | ▼ -3.1 pp |
| 2020 | 63.8% | CN¥2.31 Billion | CN¥3.63 Billion | CN¥3.13 Billion | CN¥819.57 Million | ▲ +24.5 pp |
| 2019 | 39.3% | CN¥1.63 Billion | CN¥4.13 Billion | CN¥2.70 Billion | CN¥1.07 Billion | ▲ +1.2 pp |
| 2018 | 38.1% | CN¥1.51 Billion | CN¥3.95 Billion | CN¥2.40 Billion | CN¥890.07 Million | ▲ +1.2 pp |
| 2017 | 36.9% | CN¥1.38 Billion | CN¥3.73 Billion | CN¥2.47 Billion | CN¥1.10 Billion | ▼ -5.4 pp |
| 2016 | 42.3% | CN¥1.45 Billion | CN¥3.42 Billion | CN¥2.20 Billion | CN¥753.70 Million | ▲ +36.6 pp |
| 2015 | 5.7% | CN¥119.87 Million | CN¥2.11 Billion | CN¥1.29 Billion | CN¥1.17 Billion | ▼ -52.2 pp |
| 2014 | 57.8% | CN¥1.10 Billion | CN¥1.90 Billion | CN¥1.46 Billion | CN¥364.92 Million | ▼ -9.6 pp |
| 2013 | 67.5% | CN¥1.18 Billion | CN¥1.74 Billion | CN¥1.36 Billion | CN¥188.89 Million | ▼ -8.9 pp |
| 2012 | 76.4% | CN¥1.21 Billion | CN¥1.59 Billion | CN¥1.32 Billion | CN¥109.78 Million | ▲ +1.4 pp |
| 2011 | 74.9% | CN¥1.11 Billion | CN¥1.48 Billion | CN¥1.19 Billion | CN¥85.50 Million | ▼ -10.3 pp |
| 2010 | 85.2% | CN¥1.18 Billion | CN¥1.39 Billion | CN¥1.27 Billion | CN¥90.08 Million | ▼ -2.9 pp |
| 2009 | 88.1% | CN¥1.14 Billion | CN¥1.30 Billion | CN¥1.24 Billion | CN¥103.07 Million | ▲ +77.6 pp |
| 2008 | 10.6% | CN¥18.19 Million | CN¥172.40 Million | CN¥159.06 Million | CN¥140.86 Million | ▲ +10.0 pp |
| 2007 | 0.6% | CN¥753.94K | CN¥130.56 Million | CN¥166.82 Million | CN¥166.06 Million | ▼ -14.6 pp |
| 2006 | 15.2% | CN¥21.11 Million | CN¥138.72 Million | CN¥173.88 Million | CN¥152.78 Million | — |